| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $34.3M | +120.3% |
| SG&A Expense | $19.2M | +29.9% |
| Operating Income | -$53.5M | +72.6% |
| Net Income | -$51.8M | +73.4% |
| EPS (Basic) | -$3.55 | +85.6% |
| EPS (Diluted) | -$3.55 | +85.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.5M | -76.3% |
| Short-term Investments | $205.9M | +428.0% |
| Current Assets | $227.7M | +79.2% |
| Total Assets | $230.6M | +80.9% |
| Current Liabilities | $9.1M | +74.1% |
| Total Liabilities | $9.4M | +81.0% |
| Stockholders' Equity | $221.2M | +80.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.5M | -44.4% |
| Capital Expenditures | $91K | +333.3% |
| Investing Cash Flow | -$167.1M | -1231.2% |
| Financing Cash Flow | $144.7M | +38.8% |
| Free Cash Flow | -$43.6M | -44.6% |